| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 73 |
| 1 | METHOTREXATE SODIUM | 66 |
| 2 | METHOTREXATE | 59 |
| 3 | METFORMIN | 39 |
| 4 | METFORMIN ER 500 MG | 33 |
| 5 | METFORMIN ER 750 MG | 33 |
| 6 | LEFLUNOMIDE | 31 |
| 7 | ERGOCALCIFEROL | 29 |
| 8 | PREDNISONE | 29 |
| 9 | EZETIMIBE | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 6 | 0.0077 |
| 1 | ESOMEPRAZOLE SODIUM | 6 | 0.0025 |
| 2 | NICOTINAMIDE | 6 | 0.0023 |
| 3 | RALTEGRAVIR | 12 | 0.0023 |
| 4 | ACITRETIN | 10 | 0.0020 |
| 5 | INFLIXIMAB-DYYB | 6 | 0.0017 |
| 6 | GOLD | 6 | 0.0010 |
| 7 | NEVIRAPINE | 9 | 0.0010 |
| 8 | ERGOCALCIFEROL | 29 | 0.0010 |
| 9 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 8 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 61 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 59 |
| 2 | Corticosteroid [EPC] | 46 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 42 |
| 4 | Antirheumatic Agent [EPC] | 31 |
| 5 | Provitamin D2 Compound [EPC] | 29 |
| 6 | Proton Pump Inhibitor [EPC] | 28 |
| 7 | Aminosalicylate [EPC] | 27 |
| 8 | Dietary Cholesterol Absorption Inhibitor [EPC] | 27 |
| 9 | Loop Diuretic [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 29 | 0.0010 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 13 | 0.0005 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | PCSK9 Inhibitor [EPC] | 11 | 0.0004 |
| 4 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 5 | Sulfone [EPC] | 4 | 0.0004 |
| 6 | Antirheumatic Agent [EPC] | 31 | 0.0003 |
| 7 | Dietary Cholesterol Absorption Inhibitor [EPC] | 27 | 0.0003 |
| 8 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 2 | 0.0003 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 14 | 0.0003 |